Table I.
Association between miR-302-3p expression and clinicopathological characteristics of patients with cervical cancer.
| miR-302-3p expression level | ||||
|---|---|---|---|---|
| Variables | Cases (n=68) | Low (n=39) | High (n=29) | P-value |
| Age, years | 0.799 | |||
| <55 | 24 | 13 | 11 | |
| ≥55 | 44 | 26 | 18 | |
| Tumor size, cm | 0.466 | |||
| ≤4 | 41 | 22 | 19 | |
| >4 | 27 | 17 | 10 | |
| Differentiation | 0.150 | |||
| Well-moderate | 52 | 27 | 25 | |
| Poor | 16 | 12 | 4 | |
| Clinical stage | 0.041 | |||
| I–II | 44 | 21 | 23 | |
| III–IV | 24 | 18 | 6 | |
| Lymph node metastasis | 0.019 | |||
| No | 45 | 21 | 24 | |
| Yes | 23 | 18 | 5 | |
| Distant metastasis | 0.068 | |||
| No | 59 | 31 | 28 | |
| Yes | 9 | 8 | 1 | |